| Total Revenue | | 0 | 0 | 0 | |
| Cost of Goods Sold Incl. D&A | | 4 | 3 | 0 |
| Gross Profit | | -4 | -3 | 0 |
| Selling, General and Administrative Excl. Other | | 32 | 35 | 28 |
| Research and Development | | 185 | 119 | 114 |
| Other Operating Expense | | -4 | -3 | 2 |
| Operating Income | | -216 | -154 | -144 |
| Interest Expense | | 0 | 0 | 0 |
| Unusual Expense | | — | — | — |
| Non-Operating Income (Expense) | | -10 | -16 | -9 |
| Net Income Before Taxes | | -207 | -138 | -134 |
| Income Taxes | | 0 | 0 | 0 |
| Consolidated Net Income | | -207 | -138 | -134 |
| Net Income From Continuing Operations | | -207 | -138 | -134 |
| Net Income | | -207 | -138 | -134 |
| EPS (Recurring) | | -1.34 | -1.01 | -1.77 |
| EPS (Basic, Before Extraordinaries) | | -1.34 | -1.01 | -1.77 |
| EPS (Diluted) | | -1.34 | -1.01 | -1.77 |
| EBITDA | | -204 | -135 | -132 |
| Other After Tax Adjustments | | — | — | — |
| Stock Option Compensation Expense | | — | — | — |
| Price To Earnings Ratio | | — | — | — |
| Price To Sales Ratio | | — | — | — |
| Gross Margin | | — | — | — |
| Operating Margin | | — | — | — |
| Net Margin | | — | — | — |
| Shares Outstanding | | 155 | 137 | 76 |
| Market Capitalization | | 778 | — | — |
| Operating Lease Expense | | — | — | — |
